[1] Scharf JM, Miller LL, Gauvin CA, et al.Population prevalence of Tourette syndrome:A systematic review and meta-analysis[J] .2015, 30(2): 221-228. [2] Tsetsos F, Yu D, Sul JH, et al.Synaptic processes and immune-related pathways implicated in Tourette syndrome [J].Transl Psychiatry, 2021, 11(1):56. [3] Kawikova I, Leckman JF, Kronig H, et al.Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with tourette syndrome:A preliminary study [J].Biol Psychiatry, 2007, 61(3): 273-278. [4] Yildirim Z, Karabekiroglu K, Yildiran A, et al.An examination of the relationship between regulatory T cells and symptom flare-ups in children and adolescents diagnosed with chronic tic disorder and Tourette syndrome[J] .Nord J Psychiatry, 2021,75(1):18-24. [5] Wing JB,Tay C, Sakaguchi S, et al.Control of Regulatory T Cells by Co-signal Molecules[J].Adv Exp Med Biol, 2019, 1189:179-210. [6] Leckman JF, Katsovich L, Kawikova I, et al.Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome[J].Biol Psychiatry, 2005, 57(6): 667-673. [7] Parker-Athill EC, Ehrhart J, Tan J,et al.Cytokine correlations in youth with tic disorders[J] .J Child Adolesc Psychopharmacol, 2015, 25(1): 86-92. [8] Yeon SM, Lee JH, Kang D, et al.A cytokine study of pediatric Tourette's disorder without obsessive compulsive disorder[J].Psychiatry Res, 2017, 247: 90-96. [9] Frick LR,Rapanelli M, Jindachomthong K, et al.Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum[J].Brain Behav Immun, 2018, 69: 304-311. [10] Baumgaertel C, Skripuletz T, Kronenberg J, et al.Immunity in Gilles de la Tourette-Syndrome:Results from a cerebrospinal fluid study[J].Front Neurol, 2019, 10: 732. [11] Dalsgaard S, Waltoft BL, Leckman JF, et al.Maternal history of autoimmune disease and later development of tourette syndrome in offspring[J].J Am Acad Child Adolesc Psychiatry, 2015, 54(6):495-501. [12] Giannoccaro MP, Wright SK, Vincent A.In vivo mechanisms of antibody-mediated neurological disorders:Animal models and potential implications[J].Front Neurol, 2020, 10: 1394. [13] Tay TL, Savage JC, Hui CW, et al.Microglia across the lifespan: from origin to function in brain development, plasticity and cognition [J].J Physiol (Lond), 2017, 595(6): 1929-1945. [14] Nagarajan N,Jones BW,West PJ, et al.Corticostriatal circuit defects in Hoxb8 mutant mice[J].Mol Psychiatry, 2018, 23(9), 1868-1877. [15] Frick L,Rapanelli M, Abbasi E, et al.Histamine regulation of microglia: Gene-environment interaction in the regulation of central nervous system inflammation[J].Brain Behav Immun, 2016, 57: 326-337. [16] Lennington JB, Coppola G, Kataoka-Sasaki Y, et al.Transcriptome analysis of the human striatum in Tourette syndrome[J].Biol Psychiatry, 2016, 79(5), 372-382. [17] Kumar A, Williams MT.Chugani HT.Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and Tourette syndrome:A positron emission tomographic (PET) study using 11C-[R]-PK11195[J].J Child Neurol, 2015, 30(6): 749-756. [18] Thomas Broome S, Louangaphay K, Keay KA, et al.Dopamine:An immune transmitter[J].Neural Regen Res, 2020, 15(12): 2173-2185. [19] Elgueta D, Contreras F, Prado C, et al.Dopamine receptor D3 expression is altered in CD4+ T-cells from parkinson's disease patients and its pharmacologic inhibition attenuates the motor impairment in a mouse model[J] .Front Immunol, 2019, 10: 981. [20] Levite M, Marino F,Cosentino M. Dopamine, T cells and multiple sclerosis (MS) [J].J Neural Transm (Vienna), 2017, 124(5): 525-542. [21] Addabbo F, Baglioni V, Schrag A, et al.Anti-dopamine D2 receptor antibodies in chronic tic disorders:Potential link to fluctuations of tic severity[J].Dev Med Child Neurol, 2020, 62: 1205-1212. [22] Levite M.Dopamine and T cells: dopamine receptors andpotent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases[J].Acta Physiol(Oxf), 2016, 216(1): 42-89. [23] Wu C, Qin X, Du H, et al.The immunological function of GABAergic system[J].Front Biosci (Landmark Ed), 2017, 22: 1162-1172. [24] Pogorelov V, Xu M, Smith HR, et al.Corticostriatal interactions in the generation of tic-like behaviors after local striatal disinhibition[J].Exp Neurol, 2015, 265: 122-128. [25] Perlmutter SJ, Leitman SF, Garvey MA, et al.Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood[J] .Lancet, 1999, 354(9185): 1153-1158. [26] Williams KA,Swedo SE, Farmer CA, et al.Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections[J].J Am Acad Child Adolesc Psychiatry, 2016, 55(10): 860-867. [27] Zykov VP, Shcherbina AY, Novikova EB, et al.Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children [J].Neurosci Behav Physiol, 2009, 39(7): 635-638. [28] Hoekstra PJ,Minderaa RB, Kallenberg CG.Lack of effect of intravenous immunoglobulins on tics:A double-blind placebo-controlled study[J].J Clin Psychiatry, 2004, 65(4): 537-542. |